GREGORY SMITH: Open Payments
NPI 1245204890 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 39 payments from 11 companies in 2025. Trend: 2023 $825 · 2024 $423 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $159 |
| Corcept Therapeutics | 4 | $102 |
| ABBVIE INC. | 6 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Amgen Inc. | 3 | $50 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Rybelsus, Korlym, LEQVIO, UBRELVY, NEXLETOL, Auvelity, Ozempic, INSPIRE.
Industry payments across TX — which companies pay providers there.
